The influence of cavity volumetric changes investigated by MRI on the dose distribution over the APBI therapy

The influence of cavity volumetric changes investigated by MRI on the dose distribution over the APBI therapy - The influence of cavity changes on the dose distribution over the APBI therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035947

Enrollment

Registered

2020-01-10

Start date

2018-07-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancers

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The key inclusion criteria was that APBI therapy was accomplished and on top of that in the postoperative period, MRI examinations were performed twice to obtain mri images.

Exclusion criteria

Exclusion criteria: The key exclusion criteria was that in the postoperative period, MRI examinations were not performed twice to obtain MRI images.

Design outcomes

Primary

Measure	Time frame
On the postoperative day1 and day3, (MRI1) (MRI2) were performed. These MRIbased plans were reconstructed to measure the dosimetric parameters such as V90, V150 and max doses against the skin and the chest wall. These dosimetric factors were the primary evaluation items in this study	—

Countries

Japan

Contacts

Public ContactMasahiro Kato

Tokyo nishi tokushuukai hospital radiation medical center

raijinnpower@yahoo.co.jp042-500-4433

Outcome results